Institute for Clinical and Translational Research (UL1)

临床和转化研究所 (UL1)

• 批准号: 7761091
• 负责人: Daniel Ernest Ford
• 金额: $ 0.04万
• 依托单位: JOHNS HOPKINS UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-09-17 至 2012-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7761091
• 关键词: Address; Award; Basic Science; Biometry; Clinic; Clinical; Clinical Research; Communities; Devices; Engineering; Ethics Consultation; Genetic; Goals; Image; Incubators; Influentials; Information Systems; Institutes; Institution; Interdisciplinary Study; Medical; Medicine; Methodology; Modeling; Monitor; Patient Recruitments; Pharmaceutical Preparations; Process; Proteomics; Public Health Nurses; Public Health Nursing; Research; Research Ethics; Research Personnel; Research Training; Resources; Safety; Schools; Training and Education; Translational Research; Vision; abstracting; career development; experience; innovation; programs; vaccine development

Abstract The purpose of this application is to enhance both the process and benefits of clinical andtranslational research by bringing together the diverse resources of the Johns Hopkins Medical Institutions (JHMI) and creating a new model for carrying out scientific research. This model will create a new paradigm for conducting multidisciplinary research by addressing critical barriers that currently impede the progress of basic science discoveries to the clinic. Johns Hopkins currently has two General Clinical Research Centers, two K-12 awards, one K-30 award, and one T-32 award providing substantial experience in conducting translational research and in training, education and career development of clinical and translational researchers. We propose to create a new Johns Hopkins Institute for Clinical and Translational Research whose goal is to coordinate, synergize and transform clinical and translational research within Johns Hopkins. The new Johns Hopkins Institute for Clinical and Translational Research will benefit from a broad vision supplied by an expansive external advisory board and an influential internal advisory board. The Institute will synergize many existing translational research efforts across the Johns Hopkins Schools of Engineering, Medicine, Nursing and Public Health. Research training, education and career development will be transformed to reach more learners with more tailored products. Clinical and translational researchers will be supported by new programs in biostatistics, innovative methodology, patient recruitment, navigating through regulatory offices, clinical research management systems, data safety and monitoring programs, building community bridges, research ethics consultations, and the Accelerated Translational Incubator Program (pilot program). New translational cores in drug, device and vaccine development, proteomics, genetics and imaging will create new translational research teams. We fully expect that the new Institute and the association with other CTSA medical institutions will transform how translational research is conducted at Johns Hopkins.

抽象的 此应用程序的目的是增强临床和转化的过程和效益 通过汇集约翰霍普金斯大学医疗机构 (JHMI) 的多样化资源进行研究 开创科学研究新模式。该模型将创建一个新的范式 通过解决目前阻碍进展的关键障碍来进行多学科研究 将基础科学发现应用于临床。约翰·霍普金斯大学目前拥有两个综合临床研究中心， 两项 K-12 奖项、一项 K-30 奖项和一项 T-32 奖项，提供丰富的指挥经验 转化研究以及临床和转化的培训、教育和职业发展 研究人员。我们建议创建一个新的约翰·霍普金斯临床和转化研究所 其目标是协调、协同和转变约翰斯内部的临床和转化研究 霍普金斯。新的约翰·霍普金斯临床和转化研究所将受益于广泛的 由广泛的外部顾问委员会和有影响力的内部顾问委员会提供的愿景。这 研究所将协同约翰·霍普金斯大学各学院现有的许多转化研究工作 工程、医学、护理和公共卫生。研究培训、教育和职业发展将 进行转型，以向更多学习者提供更量身定制的产品。临床和转化研究人员 将得到生物统计学、创新方法、患者招募、导航等新项目的支持 通过监管办公室、临床研究管理系统、数据安全和监测计划， 建立社区桥梁、研究伦理咨询和加速转化孵化器 计划（试点计划）。药物、设备和疫苗开发、蛋白质组学的新转化核心， 遗传学和成像将创建新的转化研究团队。我们满怀期待新研究所 与其他 CTSA 医疗机构的合作将改变转化研究的方式 在约翰·霍普金斯大学进行。